Glaukos Corporation
Founded in 1998, Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.
See below for the Latest Glaukos Corporation News, Analysis, Profit Results, Share Price Information, and Commentary.
Micro stents, macro efficiency: How a tiny device helps preserve vision
Micro stents, macro efficiency: How a tiny device helps preserve vision
Glaukos Corporation’s iStent inject W helps preserve vision by addressing high eye pressure.
Most Read
1. Singapore trials therapy that kills cancer using sound and water 2. NUHS app adds emergency wait times, pre-arrival health declarations 3. UAE’s growing cancer burden raises concerns over health system capacity 4. Singapore to roll out genetic testing for inherited cholesterol disorder 5. Singapore’s NHCS, Mayo Clinic to advance heart care and researchResource Center
Read Here
Advertise
Sign Up
Event News
The size of the global longevity industry is expected to hit $40.
Commentary
Biomedical textiles: Novel fabrics supporting enhanced patient care in Asia-Pacific